VIVS – vivosim labs, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

VIVS

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/29

07:04 pm

vivs

VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China [Yahoo! Finance]

High Report

VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China [Yahoo! Finance]

Report

1/29

04:05 pm

vivs

VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China

High Report

VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China

Report

1/23

05:09 am

vivs

VivoSim Labs (NASDAQ:VIVS) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Medium Report

VivoSim Labs (NASDAQ:VIVS) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Report

1/6

08:05 am

vivs

VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer

Low Report

VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.